skip to content

Emmaus Medical to Present at 6th Annual OneMedForum

December 19, 2012

TORRANCE, Calif., December 19, 2012 – Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, today announced that Peter Ludlum, the company’s executive vice president and CFO, will give an overview of the company’s Phase 3 sickle cell disease trial and discuss recent developments with its regenerative medicine research at the 6th Annual OneMedForum on January 8, 2013 at 9:50 a.m. P.T. at the Sir Francis Drake Hotel in San Francisco.